
Episode 36: Optimizing monoclonal antibody therapeutics for bacterial pathogens
11/10/2026
0:00
24:10
We talk with Dr. Antonio DiGiandomenico, Senior Director and Head of Microbial Antibodies and Technologies within AstraZeneca’s early Infectious Disease unit, who uses new delivery modalities to enhance monoclonal antibody therapeutics for bacterial pathogens such as Pseudomonas aeruginosa.
More episodes from "Creating Memory: Vaccines & Immunity"



Don't miss an episode of “Creating Memory: Vaccines & Immunity” and subscribe to it in the GetPodcast app.








